Apolizumab

From Wikipedia, the free encyclopedia

Apolizumab?
Therapeutic monoclonal antibody
Source Human
Target 1D10
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.[1]

[edit] References

  1. ^ Bayes M, Rabasseda X, Prous J (2003). "Gateways to clinical trials.". Methods Find Exp Clin Pharmacol 25 (9): 747–71. PMID 14685303.